ARCHIVES

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

This article is from The Cancer Letter archive.

Vol. 37 No. 24 | June 17, 2011

Download PDF Visit The Full Archive

Related Articles

5-Day Strut-based Brachytherapy Produced Low Recurrence Rates

May 25, 2012

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001

In Brief: Riley Becomes ACCC president; Rep. Green Urges Support Of Cancer Treatment Act

April 9, 1999

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

Funding Opportunities. (8-page issue).

May 2, 2003